Skip to main content
Top
Published in: Inflammation 3/2014

01-06-2014

NLRC5 Mediates Cytokine Secretion in RAW264.7 Macrophages and Modulated by the JAK2/STAT3 Pathway

Authors: Lin Li, Tao Xu, Cheng Huang, Yunyun Peng, Jun Li

Published in: Inflammation | Issue 3/2014

Login to get access

Abstract

The nucleotide-binding domain leucine-rich repeat proteins (NLRs), a class of innate immune receptors that respond to pathogen attack or cellular stress, have gained increasing attention. NLRC5 is the largest member of NLR family, which has recently been identified as a critical regulator of immune responses. In this study, we explore the role of NLRC5 in cytokine secretion and the role of the JAK2/STAT3 signaling pathway in lipopolysaccharide-induced NLRC5 expression in RAW264.7 cells. We demonstrated that overexpression of NLRC5 results in a downregulation of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) secretion; on the other hand, knockdown of NLRC5 by transfecting siRNA enhanced IL-6 and TNF-α secretion in RAW264.7 cells. These results indicated that NLRC5 plays a negative role in the regulation of IL-6 and TNF-α. Meanwhile, AG490 (a specific inhibitor of the JAK2/STAT3 signaling pathway) and JAK2 siRNA were used to manipulate JAK2/STAT3 activity. Finally, the results showed that AG490 and JAK2 siRNA inhibited NLRC5 expression and the expression levels of p-JAK2 and p-STAT3. We, for the first time, demonstrate that the inhibition of the JAK2/STAT3 signaling pathway results in decrease of NLRC5 expression.
Literature
1.
go back to reference Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783–801.PubMedCrossRef Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783–801.PubMedCrossRef
2.
go back to reference Meylan, E., J. Tschopp, and M. Karin. 2006. Intracellular pattern recognition receptors in the host response. Nature 442: 39–44.PubMedCrossRef Meylan, E., J. Tschopp, and M. Karin. 2006. Intracellular pattern recognition receptors in the host response. Nature 442: 39–44.PubMedCrossRef
3.
go back to reference Honda, K., and T. Taniguchi. 2006. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nature Reviews Immunology 6: 644–658.PubMedCrossRef Honda, K., and T. Taniguchi. 2006. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nature Reviews Immunology 6: 644–658.PubMedCrossRef
4.
go back to reference Liew, F.Y., D. Xu, E.K. Brint, and L.A. O’Neill. 2005. Negative regulation of toll-like receptor-mediated immune responses. Nature Reviews Immunology 5: 446–458.PubMedCrossRef Liew, F.Y., D. Xu, E.K. Brint, and L.A. O’Neill. 2005. Negative regulation of toll-like receptor-mediated immune responses. Nature Reviews Immunology 5: 446–458.PubMedCrossRef
5.
go back to reference Ting, J.P., D.L. Kastner, and H.M. Hoffman. 2006. CATERPILLERs, pyrin and hereditary immunological disorders. Nature Reviews Immunology 6: 183–195.PubMedCrossRef Ting, J.P., D.L. Kastner, and H.M. Hoffman. 2006. CATERPILLERs, pyrin and hereditary immunological disorders. Nature Reviews Immunology 6: 183–195.PubMedCrossRef
6.
go back to reference Inohara, Chamaillard, C. McDonald, and G. Nunez. 2005. NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annual Review of Biochemistry 74: 355–383.PubMedCrossRef Inohara, Chamaillard, C. McDonald, and G. Nunez. 2005. NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annual Review of Biochemistry 74: 355–383.PubMedCrossRef
7.
go back to reference Abrahams, V.M. 2011. The role of the Nod-like receptor family in trophoblast innate immune responses. Journal of Reproductive Immunology 88: 112–117.PubMedCrossRef Abrahams, V.M. 2011. The role of the Nod-like receptor family in trophoblast innate immune responses. Journal of Reproductive Immunology 88: 112–117.PubMedCrossRef
8.
go back to reference Martin, A.P., T. Marinkovic, C. Canasto-Chibuque, R. Latif, J.C. Unkeless, T.F. Davies, Y. Takahama, G.C. Furtado, and S.A. Lira. 2009. CCR7 deficiency in NOD mice leads to thyroiditis and primary hypothyroidism. Journal of Immunology 183: 3073–3080.CrossRef Martin, A.P., T. Marinkovic, C. Canasto-Chibuque, R. Latif, J.C. Unkeless, T.F. Davies, Y. Takahama, G.C. Furtado, and S.A. Lira. 2009. CCR7 deficiency in NOD mice leads to thyroiditis and primary hypothyroidism. Journal of Immunology 183: 3073–3080.CrossRef
10.
go back to reference Benko, S., D.J. Philpott, and S.E. Girardin. 2008. The microbial and danger signals that activate Nod-like receptors. Cytokine 43: 368–373.PubMedCrossRef Benko, S., D.J. Philpott, and S.E. Girardin. 2008. The microbial and danger signals that activate Nod-like receptors. Cytokine 43: 368–373.PubMedCrossRef
11.
go back to reference Lian, L., C. Ciraci, G. Chang, J. Hu, and S.J. Lamont. 2012. NLRC5 knockdown in chicken macrophages alters response to LPS and poly (I:C) stimulation. BMC Veterinary Research 8: 23.PubMedCentralPubMedCrossRef Lian, L., C. Ciraci, G. Chang, J. Hu, and S.J. Lamont. 2012. NLRC5 knockdown in chicken macrophages alters response to LPS and poly (I:C) stimulation. BMC Veterinary Research 8: 23.PubMedCentralPubMedCrossRef
12.
go back to reference Cui, J., L. Zhu, X. Xia, H.Y. Wang, X. Legras, J. Hong, J. Ji, P. Shen, S. Zheng, Z.J. Chen, and R.F. Wang. 2010. NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways. Cell 141: 483–496.PubMedCentralPubMedCrossRef Cui, J., L. Zhu, X. Xia, H.Y. Wang, X. Legras, J. Hong, J. Ji, P. Shen, S. Zheng, Z.J. Chen, and R.F. Wang. 2010. NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways. Cell 141: 483–496.PubMedCentralPubMedCrossRef
13.
go back to reference Neerincx, A., K. Lautz, M. Menning, E. Kremmer, P. Zigrino, M. Hosel, H. Buning, R. Schwarzenbacher, and T.A. Kufer. 2010. A role for the human nucleotide-binding domain, leucine-rich repeat-containing family member NLRC5 in antiviral responses. Journal of Biological Chemistry 285: 26223–26232.PubMedCentralPubMedCrossRef Neerincx, A., K. Lautz, M. Menning, E. Kremmer, P. Zigrino, M. Hosel, H. Buning, R. Schwarzenbacher, and T.A. Kufer. 2010. A role for the human nucleotide-binding domain, leucine-rich repeat-containing family member NLRC5 in antiviral responses. Journal of Biological Chemistry 285: 26223–26232.PubMedCentralPubMedCrossRef
14.
go back to reference Neerincx, A., G.M. Rodriguez, V. Steimle, and T.A. Kufer. 2012. NLRC5 controls basal MHC class I gene expression in an MHC enhanceosome-dependent manner. Journal of Immunology 188: 4940–4950.CrossRef Neerincx, A., G.M. Rodriguez, V. Steimle, and T.A. Kufer. 2012. NLRC5 controls basal MHC class I gene expression in an MHC enhanceosome-dependent manner. Journal of Immunology 188: 4940–4950.CrossRef
15.
go back to reference Kuenzel, S., A. Till, M. Winkler, R. Hasler, S. Lipinski, S. Jung, J. Grotzinger, H. Fickenscher, S. Schreiber, and P. Rosenstiel. 2010. The nucleotide-binding oligomerization domain-like receptor NLRC5 is involved in IFN-dependent antiviral immune responses. Journal of Immunology 184: 1990–2000.CrossRef Kuenzel, S., A. Till, M. Winkler, R. Hasler, S. Lipinski, S. Jung, J. Grotzinger, H. Fickenscher, S. Schreiber, and P. Rosenstiel. 2010. The nucleotide-binding oligomerization domain-like receptor NLRC5 is involved in IFN-dependent antiviral immune responses. Journal of Immunology 184: 1990–2000.CrossRef
16.
go back to reference Benko, S., J.G. Magalhaes, D.J. Philpott, and S.E. Girardin. 2010. NLRC5 limits the activation of inflammatory pathways. Journal of Immunology 185: 1681–1691.CrossRef Benko, S., J.G. Magalhaes, D.J. Philpott, and S.E. Girardin. 2010. NLRC5 limits the activation of inflammatory pathways. Journal of Immunology 185: 1681–1691.CrossRef
17.
go back to reference Meissner, T.B., A. Li, A. Biswas, K.H. Lee, Y.J. Liu, E. Bayir, D. Iliopoulos, P.J. van den Elsen, and K.S. Kobayashi. 2010. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. Proceedings of the National Academy of Sciences of the United States of America 107: 13794–13799.PubMedCentralPubMedCrossRef Meissner, T.B., A. Li, A. Biswas, K.H. Lee, Y.J. Liu, E. Bayir, D. Iliopoulos, P.J. van den Elsen, and K.S. Kobayashi. 2010. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. Proceedings of the National Academy of Sciences of the United States of America 107: 13794–13799.PubMedCentralPubMedCrossRef
18.
19.
go back to reference Yao, Y., and Y. Qian. 2013. Expression regulation and function of NLRC5. Protein & Cell 4: 168–175.CrossRef Yao, Y., and Y. Qian. 2013. Expression regulation and function of NLRC5. Protein & Cell 4: 168–175.CrossRef
20.
go back to reference You, Z., D. Xu, J. Ji, W. Guo, W. Zhu, and J. He. 2012. JAK/STAT signal pathway activation promotes progression and survival of human oesophageal squamous cell carcinoma. Clinical and Translational Oncology 14: 143–149.PubMedCrossRef You, Z., D. Xu, J. Ji, W. Guo, W. Zhu, and J. He. 2012. JAK/STAT signal pathway activation promotes progression and survival of human oesophageal squamous cell carcinoma. Clinical and Translational Oncology 14: 143–149.PubMedCrossRef
21.
go back to reference Kisseleva, T., S. Bhattacharya, J. Braunstein, and C.W. Schindler. 2002. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 285: 1–24.PubMedCrossRef Kisseleva, T., S. Bhattacharya, J. Braunstein, and C.W. Schindler. 2002. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 285: 1–24.PubMedCrossRef
22.
go back to reference Kawasaki, M., M. Fujishiro, A. Yamaguchi, K. Nozawa, H. Kaneko, Y. Takasaki, K. Takamori, H. Ogawa, and I. Sekigawa. 2011. Possible role of the JAK/STAT pathways in the regulation of T cell-interferon related genes in systemic lupus erythematosus. Lupus 20: 1231–1239.PubMedCrossRef Kawasaki, M., M. Fujishiro, A. Yamaguchi, K. Nozawa, H. Kaneko, Y. Takasaki, K. Takamori, H. Ogawa, and I. Sekigawa. 2011. Possible role of the JAK/STAT pathways in the regulation of T cell-interferon related genes in systemic lupus erythematosus. Lupus 20: 1231–1239.PubMedCrossRef
23.
go back to reference Kang, J.W., and S.M. Lee. 2012. Melatonin inhibits type 1 interferon signaling of toll-like receptor 4 via heme oxygenase-1 induction in hepatic ischemia/reperfusion. Journal of Pineal Research 53: 67–76.PubMedCrossRef Kang, J.W., and S.M. Lee. 2012. Melatonin inhibits type 1 interferon signaling of toll-like receptor 4 via heme oxygenase-1 induction in hepatic ischemia/reperfusion. Journal of Pineal Research 53: 67–76.PubMedCrossRef
24.
go back to reference Duan, W., Y. Yang, J. Yan, S. Yu, J. Liu, J. Zhou, J. Zhang, Z. Jin, and D. Yi. 2012. The effects of curcumin post-treatment against myocardial ischemia and reperfusion by activation of the JAK2/STAT3 signaling pathway. Basic Research in Cardiology 107: 263.PubMedCrossRef Duan, W., Y. Yang, J. Yan, S. Yu, J. Liu, J. Zhou, J. Zhang, Z. Jin, and D. Yi. 2012. The effects of curcumin post-treatment against myocardial ischemia and reperfusion by activation of the JAK2/STAT3 signaling pathway. Basic Research in Cardiology 107: 263.PubMedCrossRef
25.
go back to reference Betts, B.C., O. Abdel-Wahab, S.A. Curran, E.T. St Angelo, P. Koppikar, G. Heller, R.L. Levine, and J.W. Young. 2011. Janus kinase-2 inhibition induces durable tolerance to alloantigen by human dendritic cell-stimulated T cells yet preserves immunity to recall antigen. Blood 118: 5330–5339.PubMedCentralPubMedCrossRef Betts, B.C., O. Abdel-Wahab, S.A. Curran, E.T. St Angelo, P. Koppikar, G. Heller, R.L. Levine, and J.W. Young. 2011. Janus kinase-2 inhibition induces durable tolerance to alloantigen by human dendritic cell-stimulated T cells yet preserves immunity to recall antigen. Blood 118: 5330–5339.PubMedCentralPubMedCrossRef
26.
go back to reference Quintas-Cardama, A. 2013. The role of Janus kinase 2 (JAK2) in myeloproliferative neoplasms: therapeutic implications. Leukemia Research 37: 465–472.PubMedCrossRef Quintas-Cardama, A. 2013. The role of Janus kinase 2 (JAK2) in myeloproliferative neoplasms: therapeutic implications. Leukemia Research 37: 465–472.PubMedCrossRef
27.
go back to reference Zhang, W., Q. Sun, X. Gao, Y. Jiang, R. Li, and J. Ye. 2013. Anti-inflammation of spirocyclopiperazinium salt compound LXM-10 targeting alpha7 nAChR and M4 mAChR and inhibiting JAK2/STAT3 pathway in rats. PLoS One 8: e66895.PubMedCentralPubMedCrossRef Zhang, W., Q. Sun, X. Gao, Y. Jiang, R. Li, and J. Ye. 2013. Anti-inflammation of spirocyclopiperazinium salt compound LXM-10 targeting alpha7 nAChR and M4 mAChR and inhibiting JAK2/STAT3 pathway in rats. PLoS One 8: e66895.PubMedCentralPubMedCrossRef
28.
go back to reference Terrell, A.M., P.R. Crisostomo, G.M. Wairiuko, M. Wang, E.D. Morrell, and D.R. Meldrum. 2006. Jak/STAT/SOCS signaling circuits and associated cytokine-mediated inflammation and hypertrophy in the heart. Shock 26: 226–234.PubMedCrossRef Terrell, A.M., P.R. Crisostomo, G.M. Wairiuko, M. Wang, E.D. Morrell, and D.R. Meldrum. 2006. Jak/STAT/SOCS signaling circuits and associated cytokine-mediated inflammation and hypertrophy in the heart. Shock 26: 226–234.PubMedCrossRef
29.
go back to reference Karin, M., T. Lawrence, and V. Nizet. 2006. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 124: 823–835.PubMedCrossRef Karin, M., T. Lawrence, and V. Nizet. 2006. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 124: 823–835.PubMedCrossRef
30.
go back to reference Wang, R.F., Y. Miyahara, and H.Y. Wang. 2008. Toll-like receptors and immune regulation: implications for cancer therapy. Oncogene 27: 181–189.PubMedCrossRef Wang, R.F., Y. Miyahara, and H.Y. Wang. 2008. Toll-like receptors and immune regulation: implications for cancer therapy. Oncogene 27: 181–189.PubMedCrossRef
31.
go back to reference Hoffman, H.M., and S.D. Brydges. 2011. Genetic and molecular basis of inflammasome-mediated disease. Journal of Biological Chemistry 286: 10889–10896.PubMedCentralPubMedCrossRef Hoffman, H.M., and S.D. Brydges. 2011. Genetic and molecular basis of inflammasome-mediated disease. Journal of Biological Chemistry 286: 10889–10896.PubMedCentralPubMedCrossRef
32.
go back to reference Allen, I.C. 2011. A NOD to zebrafish models of inflammatory bowel disease pathogenesis. Disease Models & Mechanisms 4: 711–712.CrossRef Allen, I.C. 2011. A NOD to zebrafish models of inflammatory bowel disease pathogenesis. Disease Models & Mechanisms 4: 711–712.CrossRef
33.
go back to reference Rothwarf, D.M., E. Zandi, G. Natoli, and M. Karin. 1998. IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature 395: 297–300.PubMedCrossRef Rothwarf, D.M., E. Zandi, G. Natoli, and M. Karin. 1998. IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature 395: 297–300.PubMedCrossRef
34.
go back to reference Koppula, S., W.J. Kim, J. Jiang, D.W. Shim, N.H. Oh, T.J. Kim, T.B. Kang, and K.H. Lee. 2013. Carpesium macrocephalum attenuates lipopolysaccharide-induced inflammation in macrophages by regulating the NF-kappa B/I kappa B-alpha, Akt, and STAT signaling pathways. American Journal of Chinese Medicine 41: 927–943.PubMedCrossRef Koppula, S., W.J. Kim, J. Jiang, D.W. Shim, N.H. Oh, T.J. Kim, T.B. Kang, and K.H. Lee. 2013. Carpesium macrocephalum attenuates lipopolysaccharide-induced inflammation in macrophages by regulating the NF-kappa B/I kappa B-alpha, Akt, and STAT signaling pathways. American Journal of Chinese Medicine 41: 927–943.PubMedCrossRef
35.
go back to reference Fan GW, Zhang Y, Jiang X, Zhu Y, Wang B, Su L, Cao W, Zhang H, Gao X. 2013. Anti-inflammatory activity of baicalein in LPS-stimulated RAW264.7 macrophages via estrogen receptor and NF-kappaB-dependent pathways. Inflammation 36:1584–1591. Fan GW, Zhang Y, Jiang X, Zhu Y, Wang B, Su L, Cao W, Zhang H, Gao X. 2013. Anti-inflammatory activity of baicalein in LPS-stimulated RAW264.7 macrophages via estrogen receptor and NF-kappaB-dependent pathways. Inflammation 36:1584–1591.
Metadata
Title
NLRC5 Mediates Cytokine Secretion in RAW264.7 Macrophages and Modulated by the JAK2/STAT3 Pathway
Authors
Lin Li
Tao Xu
Cheng Huang
Yunyun Peng
Jun Li
Publication date
01-06-2014
Publisher
Springer US
Published in
Inflammation / Issue 3/2014
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-013-9804-y

Other articles of this Issue 3/2014

Inflammation 3/2014 Go to the issue